1. A randomized trial of the safety, pharmacokinetics and pharmacodynamics of edoxaban, an oral factor Xa inhibitor, following a switch from warfarin. (15th March 2013) Authors: Mendell, Jeanne; Noveck, Robert J.; Shi, Minggao Journal: British journal of clinical pharmacology Issue: Volume 75:Number 4(2013:Apr.) Page Start: 966 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Review of Antithrombotic Therapy and the Rationale and Design of the Randomized Edoxaban in Patients With Peripheral Artery Disease (ePAD) Trial Adding Edoxaban or Clopidogrel to Aspirin After Femoropopliteal Endovascular Intervention. (April 2015) Authors: Tangelder, Marco J. D.; Nwachuku, Chuke E.; Jaff, Michael; Baumgartner, Iris; Duggal, Anil; Adams, George; Ansel, Gary; Grosso, Michael; Mercuri, Michele; Shi, Minggao; Minar, Erich; Moll, Frans L. Journal: Journal of endovascular therapy Issue: Volume 22:Number 2(2015:Apr.) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Issue 9984 (6th June 2015) Authors: Ruff, Christian T; Giugliano, Robert P; Braunwald, Eugene; Morrow, David A; Murphy, Sabina A; Kuder, Julia F; Deenadayalu, Naveen; Jarolim, Petr; Betcher, Joshua; Shi, Minggao; Brown, Karen; Patel, Indravadan; Mercuri, Michele; Antman, Elliott M Journal: Lancet Issue: Volume 385:Issue 9984(2015) Page Start: 2288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial. (15th April 2018) Authors: Cavallari, Ilaria; Ruff, Christian T.; Nordio, Francesco; Deenadayalu, Naveen; Shi, Minggao; Lanz, Hans; Rutman, Howard; Mercuri, Michele F.; Antman, Elliott M.; Braunwald, Eugene; Giugliano, Robert P. Journal: International journal of cardiology Issue: Volume 257(2018) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial. Issue 2 (23rd February 2016) Authors: Xu, Haiyan; Ruff, Christian T.; Giugliano, Robert P.; Murphy, Sabina A.; Nordio, Francesco; Patel, Indravadan; Shi, Minggao; Mercuri, Michele; Antman, Elliott M.; Braunwald, Eugene Journal: Journal of the American Heart Association Issue: Volume 5:Issue 2(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial. Issue 2 (February 2016) Authors: Xu, Haiyan; Ruff, Christian T.; Giugliano, Robert P.; Murphy, Sabina A.; Nordio, Francesco; Patel, Indravadan; Shi, Minggao; Mercuri, Michele; Antman, Elliott M.; Braunwald, Eugene Journal: Journal of the American Heart Association Issue: Volume 5:Issue 2(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine. (23rd September 2016) Authors: Parasrampuria, Dolly A.; Mendell, Jeanne; Shi, Minggao; Matsushima, Nobuko; Zahir, Hamim; Truitt, Kenneth Journal: British journal of clinical pharmacology Issue: Volume 82:Number 6(2016:Dec.) Page Start: 1591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min. Issue 5 (7th December 2021) Authors: Yin, Ophelia; Kakkar, Tarundeep; Duggal, Anil; Kotsuma, Masakatsu; Shi, Minggao; Lanz, Hans; Grosso, Michael A. Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 5(2022) Page Start: 666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial. Issue 3 (September 2019) Authors: Park, Sungha; Bergmark, Brian A.; Shi, Minggao; Lanz, Hans-Joachim; Chung, Namsik; Ruff, Christian T.; Antman, Elliott M.; Braunwald, Eugene; Giugliano, Robert P. Journal: Hypertension Issue: Volume 74:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF‐TIMI 48. (28th June 2016) Authors: Magnani, Giulia; Giugliano, Robert P.; Ruff, Christian T.; Murphy, Sabina A.; Nordio, Francesco; Metra, Marco; Moccetti, Tiziano; Mitrovic, Veselin; Shi, Minggao; Mercuri, Michele; Antman, Elliott M.; Braunwald, Eugene Journal: European journal of heart failure Issue: Volume 18:Number 9(2016) Page Start: 1153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗